Apoptosis, Cell Cycle, And Cancer Flashcards

1
Q

G1 checkpoint

A

Occurs in response to DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Restriction point

A

Occurs in response to not enough growth factors. This restriction will keep the cell in G0 until GFs are obtained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

G2 checkpoint

A

Ensures duplication integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metaphase checkpoint

A

Ensures chromosomes are attached to mitotic spindle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What pathways will cells follow after the cell cycle?

A

Apoptosis, cell proliferation, or cell differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Myc-TF

A

Will drive cell proliferation by activating G1-CDK to phosphorylate Rb. Rb will then release E2F that will move the cell cycle from G1 to S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

E2F drives expression of what?

A

Cyclin E and cyclin A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CDK2 and Rb

A

CDK2 will hyperphosphorylate Rb to activate E2F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cyclin

A

Cyclins must interact with CDK for CDK to be activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is required for full activation of Clycin-CDK?

A

CDK activating kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

WEE1

A

WEE1 will phosphorylate the roof of CDK to prevent cyclin from binding in its active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CAK

A

In the inactive state, the T loop will be covering the CDK active site. When cyclin binds, the T loop will move out of the active site and CAK will be able to bind and full activate the CDK-cyclin complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

G1 cyclins and CDKs

A

Cyclin D, CDK 4 and 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

G1/S cyclin and CDK

A

Cyclin E and CDK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

S phase cyclin and CDKs

A

Cyclin A and CDK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

M phase cyclin and CDK

A

Cyclin A and B, CDK1

17
Q

Cyclin D purpose

A

Helps passage of cells from restriction point to G1

18
Q

Cyclin E purpose

A

Helps cells commit to DNA replication and enter S phase

19
Q

Cyclin A purpose

A

Necessary for initiation of DNA synthesis

20
Q

Cyclin A ad B purpose

A

Necessary for nuclear division during mitosis

21
Q

Cdc25

A

Will dephosphorylate the roof site to increase CDK activity

22
Q

P27

A

Bind CDK and cyclin to inhibit it

CKI

23
Q

APC/C

A

Regulates progression from metaphase to anaphase because Cyclin-S and Cyclin-M need to decrease activity.

Cdc20 will activate so that cyclins can be polyubiquitinated and degraded by proteosomes

24
Q

What normally degrades p53?

A

MDM2 - an E3 ubiquitin ligase

25
Q

P21

A

Activation of p53 leads to transcription of CKI p21 that will bind and inactive cyclin-CDK and cause cell arrest

Can inhibit all cyclin/CDK complexes but is mainly associated with CDK2

26
Q

Pro-apoptotic

A

P53 BAX,BAK

27
Q

Pro survival

A

BCL-1, BCL-Xl

28
Q

BRCA1 is a result of a mutation in what receptor?

A

HER2 to NEU due to a Val —> Gln mutation

29
Q

Mutated p53

A

Located on chromosome 17 and monitors check points of cell cycle. Mutation is observed in more than 50% of all human tumors

30
Q

RB mutation

A

Regulates G1 phase of cell cycle. Located on chromosome 13 and seen in retinoblastoma

31
Q

APC mutation

A

On chr 5, regulates cell proliferation. It’s observed in familial adenomatous polyposis. Leads to colon cancer

32
Q

DCC mutation

A

Plays a role in cell proliferation, migration, and apoptosis. Located on Chr 18 and mutations are seen in colon cancer

33
Q

BRCA1/BRCA2 mutation

A

Chromosome 17, plays a role in DNA repair and apoptosis

Observed in breast cancer

34
Q

NF-1 mutation

A

Chr 17. Encodes GAP which will turn off activated RAS protein. Mutations in NF-1 lead to neurofibromatosis